These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2476018)

  • 21. Modulation of adrenergic receptors during left ventricular hypertrophy development and after regression by captopril.
    Martínez ML; Fernández-Tomé P; López-Miranda V; Colado MI; Delgado C
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):505-11. PubMed ID: 10511124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrepant recovery course of sympathetic neuronal function and beta-adrenoceptors in rat hearts after reperfusion following transient ischemia.
    Kato B; Nozawa T; Igarashi N; Nonomura M; Fujii N; Igawa A; Asanoi H; Yamada Y; Inoue M; Inoue H
    J Nucl Med; 2004 Jun; 45(6):1074-80. PubMed ID: 15181143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of left ventricular hypertrophy, beta-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis.
    Wiesner RJ; Ehmke H; Faulhaber J; Zak R; Rüegg JC
    Circulation; 1997 Mar; 95(5):1253-9. PubMed ID: 9054857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remodelling of left ventricular after banding of ascending aorta in the rat.
    Imamura M; Schluchter M; Fouad-Tarazi FM
    Cardiovasc Res; 1990 Aug; 24(8):641-6. PubMed ID: 2146017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presynaptic regulation of norepinephrine release in a model of nonfailing hypertrophied myocardium.
    Burgdorf C; Richardt D; Kurz T; Richardt G
    J Cardiovasc Pharmacol; 2003 May; 41(5):813-6. PubMed ID: 12717114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of adrenergic mechanisms in the development of cardiac hypertrophy.
    Malik AB; Geha AS
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):796-800. PubMed ID: 128762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of sympathetic presynaptic components in rat left ventricle during ligation of abdominal aorta.
    Nyquist-Battie C; Cochran PK; Evans VR; Hitchcock JM; Unal C
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1547-54. PubMed ID: 8897951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.
    Ostman-Smith I
    Br J Pharmacol; 1995 Nov; 116(6):2703-9. PubMed ID: 8590993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased sympathetic nervous system activity in rat spleen and heart following vitamin A depletion.
    Nakano K; Mizutani R
    J Nutr Sci Vitaminol (Tokyo); 1984 Apr; 30(2):163-70. PubMed ID: 6088738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adrenergic receptor systems in canine left ventricular hypertrophy.
    Chiba M; Shida M; Miyazaki Y; Koga Y; Toshima H
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():39-47. PubMed ID: 2560796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure.
    Kimura K; Kanazawa H; Ieda M; Kawaguchi-Manabe H; Miyake Y; Yagi T; Arai T; Sano M; Fukuda K
    Auton Neurosci; 2010 Aug; 156(1-2):27-35. PubMed ID: 20335077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between renin-angiotensin and sympathetic nervous systems in a rat model of pressure overload cardiac hypertrophy.
    Rathore HA; Munavvar AS; Abdullah NA; Khan AH; Fathihah B; NurJannah MH; Raisa NA; Anand Swarup KR; Abdullah MH; Salman IM; Johns EJ
    Auton Autacoid Pharmacol; 2009 Oct; 29(4):171-80. PubMed ID: 19740088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects.
    Lake CR; Ziegler MG
    Circulation; 1978 Apr; 57(4):774-8. PubMed ID: 630687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ontogeny of mammalian cardiac alpha 1-adrenergic receptors.
    Yamada S; Yamamura HI; Roeske WR
    Eur J Pharmacol; 1980 Nov; 68(2):217-21. PubMed ID: 6258929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic activity and cardiac adrenergic receptors in one-kidney, one clip hypertension in rats.
    Vlachakis ND; Ransom F; Kogosov E; Woodcock E; Alexander N; Maronde RF
    Hypertension; 1984; 6(5):654-9. PubMed ID: 6500672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of nerve impulses on adrenergic storage vesicles in rat heart.
    Nelson DL; Molinoff PB
    J Pharmacol Exp Ther; 1976 Jul; 198(1):112-22. PubMed ID: 933001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered neuropeptide Y effects on noradrenaline levels in the paraventricular nucleus of rats following aortic constriction.
    Woo ND; Ganguly PK
    Can J Cardiol; 1994 May; 10(4):471-6. PubMed ID: 8193992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diminished neuropeptide Y and dopamine beta-hydroxylase immunoreactivity in a guinea pig model of left ventricular hypertrophy.
    Love S; Nyquist-Battie C; DiMaggio DA; Farah JM; Chronwall BM
    Cardiovasc Res; 1993 Mar; 27(3):494-9. PubMed ID: 8490950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered renal dopamine receptors during development of cardiac hypertrophy.
    Ganguly PK; Mukherjee K; Chen Y
    Am J Physiol; 1992 May; 262(5 Pt 1):E569-73. PubMed ID: 1317107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.